Insurers have reported a growth in breast-lump disclosure on application forms but these are often benign. Anne Llewellyn explains the underwriting implications of breast disease
Breast cancer is the UK's most common cancer and accounts for nearly a third of all cancers in women. Some 46,000 are diagnosed with breast cancer each year and more than 1,000 die of the disease each month. These are frightening statistics and it is not surprising that awareness has increased through pink ribbon campaigns, media coverage and high-profile charity promotions. In 1986, the Forrest Report recommended a national breast-screening programme to detect and remove tumours before they grew to larger and more lethal sizes and before spreading to the lymph nodes. It was estimated th...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes